Search results
AstraZeneca admits its Covid vaccine can cause rare side effect in court documents for first time
Daily Telegraph· 3 days agoIn a letter of response sent in May 2023, AstraZeneca told lawyers for Mr Scott that “we do not...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 7 minutes agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But...
Benzinga via Yahoo Finance· 2 days agoEuropean pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of...
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
The Independent via Yahoo News· 2 days agoPharmaceutical giant AstraZeneca has admitted that its widely used Covid vaccine, branded...
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack...
The Conversation via Yahoo News· 3 hours agoCancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA ...
New mRNA cancer vaccine triggers immune system to fight aggressive brain tumour
PA Media: Science via Yahoo News· 3 hours agoA new personalised brain cancer jab can trigger the body’s own immune system to attack the most...
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 2 hours agoPharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a...
New vaccine triggers body to fight deadly brain tumors
WFMZ Eastern Pennsylvania and Western New Jersey· 2 hours agoA new personalized cancer jab triggers a "fierce" immune response to fight deadly brain tumors, say...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 3 hours agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
mRNA Brain Cancer Vaccine Shows Promise In Early Trials In Humans – And Dogs
IFLScience· 3 hours agoA new mRNA vaccine candidate for aggressive brain cancer has shown promise in a small clinical trial...